The absence of institutional selling and the strong passive inflow — particularly UBS's $1.7M增持 — suggests growing confidence in ETON's valuation or pipeline prospects; traders should monitor for follow-on buying, upcoming catalysts, or potential inclusion in broader index rebalancing.
Executive Summary
Three major passive institutions — Morgan Stanley, Wells Fargo, and UBS — significantly increased their positions in Eton Pharmaceuticals during Q4 2024, collectively adding $1.9M in new holdings with no institutional selling observed. The cluster is driven by large percentage increases in share count, including new positions and doubling activity, signaling renewed institutional interest in the small-cap biopharma stock.
Key Financial Metrics
Institutional Positions
Net institutional flow: $1.9M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +2695.1% | $176.0K | $173.0K |
| Wells Fargo | NEW | +0% | $13.0K | $13.0K |
| UBS | DOUBLED | +611.7% | $1.8M | $1.7M |
Key Facts
- Morgan Stanley doubled its position, increasing shares from 472 to 13.2K (+2,695.1%) with a value increase of $173K
- Wells Fargo established a new position of 1.0K shares valued at $13K
- UBS doubled its holdings from 19.0K to 135.4K shares, increasing position value by $1.7M to $1.8M
- No institutional selling was reported in the quarter
Financial Impact
3 institutions accumulated $1.9M in net new positions during Q4 2024
Risk Factors
- All buyers are mega-passive institutions, suggesting the move may reflect index rebalancing rather than fundamental conviction
- The total dollar amount ($1.9M net buy) is small relative to ETON's $456M market cap, limiting immediate price impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ETON-2024-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $52.88 | awaiting T+60 | — | — |
Oct 6, 2026 20d ago | 144 | $54.88 | awaiting T+60 | — | — |
Sep 28, 2026 28d ago | 8-K | $59.18 | awaiting T+60 | — | — |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | — |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | — |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | — |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | — |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | — |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | — |
Aug 4, 2026 11w ago | 8-K | $45.83 | awaiting T+60 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers